What is luteinizing hormone (LH)?
Luteinizing hormone (LH) is a pituitary hormone that signals the testes to produce testosterone, making it a key marker evaluated during testosterone replacement therapy screening.
Luteinizing hormone originates in the anterior pituitary gland and travels through the bloodstream to stimulate Leydig cells in the testes, triggering testosterone synthesis and release. In men, LH acts as the hormonal messenger that maintains baseline testosterone production throughout the day. When LH levels fall or fail to rise appropriately, testosterone output declines, even if the testes themselves are functioning normally.
Clinicians evaluate LH alongside total and free testosterone during TRT evaluation because the hormone paints a fuller picture of where a problem originates. A low testosterone reading paired with low or low-normal LH suggests the pituitary or hypothalamus may not be signaling properly (secondary hypogonadism). Conversely, high LH with low testosterone often indicates the testes themselves are not responding to stimulation (primary hypogonadism). Understanding this distinction helps TRT providers in Miami FL choose whether testosterone replacement, clomiphene, or other interventions best suit the patient's physiology.
LH also fluctuates naturally across the day and across seasons, so a single reading offers limited information. Most clinics order LH as part of a baseline panel that includes testosterone, FSH (follicle-stimulating hormone), and sometimes prolactin to build a comprehensive hormonal profile before starting therapy.